Cargando…
Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer
Although curative resection is the current treatment of choice for localized non-small-cell lung cancer (NSCLC), patients show a wide spectrum of survival even after complete resection of pathological stage I NSCLC. Thus, identifying molecular biomarkers that help to accurately select patients at hi...
Autores principales: | Harada, Hiroaki, Miyamoto, Kazuaki, Yamashita, Yoshinori, Taniyama, Kiyomi, Mihara, Kazuko, Nishimura, Mitsuki, Okada, Morihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618624/ https://www.ncbi.nlm.nih.gov/pubmed/26276761 http://dx.doi.org/10.1002/cam4.507 |
Ejemplares similares
-
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma
por: Jiang, Di M., et al.
Publicado: (2020) -
Multidisciplinary Team-Based Approach for Comprehensive Preoperative Pulmonary Rehabilitation Including Intensive Nutritional Support for Lung Cancer Patients
por: Harada, Hiroaki, et al.
Publicado: (2013) -
Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer
por: Watt, David G., et al.
Publicado: (2017) -
Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer
por: Tu, Ru‐Hong, et al.
Publicado: (2017) -
A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)
por: Kunitoh, Hideo, et al.
Publicado: (2020)